108 related articles for article (PubMed ID: 35467255)
1. CRISPR/Cas9-Mediated Disruption of ZNF543 Gene: An Approach Toward Discovering Its Relation to TRIM28 Gene in Parkinson's Disease.
Hashemabadi M; Sasan H; Amandadi M; Esmaeilzadeh-Salestani K; Esmaeili-Mahani S; Ravan H
Mol Biotechnol; 2023 Feb; 65(2):243-251. PubMed ID: 35467255
[TBL] [Abstract][Full Text] [Related]
2. Generation of TRIM28 Knockout K562 Cells by CRISPR/Cas9 Genome Editing and Characterization of TRIM28-Regulated Gene Expression in Cell Proliferation and Hemoglobin Beta Subunits.
Chang YJ; Kang Z; Bei J; Chou SJ; Lu MJ; Su YL; Lin SW; Wang HH; Lin S; Chang CJ
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743282
[TBL] [Abstract][Full Text] [Related]
3. Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.
Chang YJ; Lin S; Kang ZF; Shen BJ; Tsai WH; Chen WC; Lu HP; Su YL; Chou SJ; Lin SY; Lin SW; Huang YJ; Wang HH; Chang CJ
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372979
[TBL] [Abstract][Full Text] [Related]
4. TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer.
Agarwal N; Rinaldetti S; Cheikh BB; Zhou Q; Hass EP; Jones RT; Joshi M; LaBarbera DV; Knott SRV; Cech TR; Theodorescu D
Proc Natl Acad Sci U S A; 2021 Sep; 118(38):. PubMed ID: 34518220
[TBL] [Abstract][Full Text] [Related]
5. Clustered regularly interspaced short palindromic repeats as an advanced treatment for Parkinson's disease.
Mehmood A; Ali W; Din ZU; Song S; Sohail M; Shah W; Guo J; Guo RY; Ilahi I; Shah S; Al-Shaebi F; Zeb L; Asiamah EA; Al-Dhamin Z; Bilal H; Li B
Brain Behav; 2021 Aug; 11(8):e2280. PubMed ID: 34291612
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of TRIM28 Enhances the Expression of IFN-β and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial Cells.
Krischuns T; Günl F; Henschel L; Binder M; Willemsen J; Schloer S; Rescher U; Gerlt V; Zimmer G; Nordhoff C; Ludwig S; Brunotte L
Front Immunol; 2018; 9():2229. PubMed ID: 30323812
[TBL] [Abstract][Full Text] [Related]
7. CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson's Disease.
Safari F; Hatam G; Behbahani AB; Rezaei V; Barekati-Mowahed M; Petramfar P; Khademi F
Cell Mol Neurobiol; 2020 May; 40(4):477-493. PubMed ID: 31773362
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease
Yoon HH; Ye S; Lim S; Jo A; Lee H; Hong F; Lee SE; Oh SJ; Kim NR; Kim K; Kim BJ; Kim H; Lee CJ; Nam MH; Hur JW; Jeon SR
CRISPR J; 2022 Feb; 5(1):95-108. PubMed ID: 35191750
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation.
Kim H; Ham S; Jo M; Lee GH; Lee YS; Shin JH; Lee Y
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28972555
[TBL] [Abstract][Full Text] [Related]
10. TRIM28 regulates Igf2-H19 and Dlk1-Gtl2 imprinting by distinct mechanisms during sheep fibroblast proliferation.
Luo J; Zhang Y; Guo Y; Tang H; Wei H; Liu S; Wang X; Wang L; Zhou P
Gene; 2017 Dec; 637():152-160. PubMed ID: 28947302
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9-mediated pinpoint microbial genome editing aided by target-mismatched sgRNAs.
Lee HJ; Kim HJ; Lee SJ
Genome Res; 2020 May; 30(5):768-775. PubMed ID: 32327447
[TBL] [Abstract][Full Text] [Related]
12. Negative Regulation of Erythroid Differentiation via the CBX8-TRIM28 Axis.
Kim HJ; Park JW; Kang JY; Seo SB
Mol Cells; 2021 Jul; 44(7):444-457. PubMed ID: 34253692
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-mediated genome editing of splicing mutation causing congenital hearing loss.
Ryu N; Kim MA; Choi DG; Kim YR; Sonn JK; Lee KY; Kim UK
Gene; 2019 Jun; 703():83-90. PubMed ID: 30898719
[TBL] [Abstract][Full Text] [Related]
14. DUF3669, a "domain of unknown function" within ZNF746 and ZNF777, oligomerizes and contributes to transcriptional repression.
Al Chiblak M; Steinbeck F; Thiesen HJ; Lorenz P
BMC Mol Cell Biol; 2019 Dec; 20(1):60. PubMed ID: 31856708
[TBL] [Abstract][Full Text] [Related]
15. The bromodomain protein TRIM28 controls the balance between growth and invasiveness in melanoma.
Nyberg WA; Velasquez-Pulgarin DA; He T; Sjöstrand M; Pellé L; Covacu R; Espinosa A
EMBO Rep; 2023 Jan; 24(1):e54944. PubMed ID: 36341538
[TBL] [Abstract][Full Text] [Related]
16. The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity.
Lin J; Guo D; Liu H; Zhou W; Wang C; Müller I; Kossenkov AV; Drapkin R; Bitler BG; Helin K; Zhang R
Cancer Immunol Res; 2021 Dec; 9(12):1413-1424. PubMed ID: 34848497
[TBL] [Abstract][Full Text] [Related]
17. Plasmid-based CRISPR-Cas9 system efficacy for introducing targeted mutations in CD81 gene of MDA-MB-231 cell line.
Arbabi Zaboli K; Rahimi H; Thekkiniath J; Taromchi AH; Kaboli S
Folia Histochem Cytobiol; 2022; 60(1):13-23. PubMed ID: 35157300
[TBL] [Abstract][Full Text] [Related]
18. TRIM28 and TRIM27 are required for expressions of PDGFRβ and contractile phenotypic genes by vascular smooth muscle cells.
Wang Y; Hao Y; Zhao Y; Huang Y; Lai D; Du T; Wan X; Zhu Y; Liu Z; Wang Y; Wang N; Zhang P
FASEB J; 2020 May; 34(5):6271-6283. PubMed ID: 32162409
[TBL] [Abstract][Full Text] [Related]
19. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated gene knockout in human adipose stem/progenitor cells.
Mandl M; Ritthammer H; Ejaz A; Wagner SA; Hatzmann FM; Baumgarten S; Viertler HP; Zwierzina ME; Mattesich M; Schiller V; Rauchenwald T; Ploner C; Waldegger P; Pierer G; Zwerschke W
Adipocyte; 2020 Dec; 9(1):626-635. PubMed ID: 33070670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
